Visualization of Metastatic Lung Cancer with TiNIR

Tomography. 2023 Jun 21;9(4):1187-1195. doi: 10.3390/tomography9040096.

Abstract

The development of efficient biomarkers and probes for monitoring and treating cancer, specifically metastatic cancer, is a critical research area that can have a significant impact on both patient outcomes and drug discovery. In this context, TiNIR has been developed to detect tumor-initiating cells (TICs), with heme oxygenase 2 (HO2) as a promising therapeutic biomarker for tumor-initiating cells. In this study, TiNIR has demonstrated its effectiveness as an in vivo metastatic lung cancer tracker, highlighting its potential as a valuable tool in cancer research and therapy. The development of innovative approaches that selectively target metastatic cancers represents a promising avenue for improving survival rates and enhancing the quality of life of cancer patients.

Keywords: TiNIR; biomarkers; heme oxygenase 2 (HO2); metastatic lung cancer; probe.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Lung Neoplasms*
  • Quality of Life*

Grants and funding

This research was supported by the Sunchon National University Research Fund in 2021 (Grant number: 2021-0251) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2021R1C1C1006874). This research was supported by Basic Science Research Institute Fund (2021R1A6A1A10042944) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2023R1A2C300453411).